Table 2 The changes in study outcomes for all participants at 12 months (N = 111)
Outcome | At baseline mean (SD) | Change at 12 months mean (95% CI) | P-value |
|---|---|---|---|
Office SBP, mmHg | 173 (20) | − 22 (− 27 to − 18) | < 0.001 |
Office DBP, mmHg | 102 (12) | − 13 (− 15 to − 10) | < 0.001 |
Home SBP, mmHg | 153 (13) | − 15 (− 18 to − 11) | < 0.001 |
Home DBP, mmHg | 92 (7) | − 10 (− 12 to − 8) | < 0.001 |
EQ-5D | 0.872 (0.153) | − 0.045 (− 0.076 to − 0.015) | 0.004 |
EQ-5D VAS | 77 (14) | 1 (− 1 to 3) | 0.32 |
Weight, kg | 84.1 (17.2) | 0.0 (0.7 to 0.7) | 0.94 |
Waist circumference, cm | 101 (16) | − 1 (− 3 to 1) | 0.21 |
Total cholesterol, mmol/l | 5.36 (1.11) | − 0.37 (− 0.56 to − 0.19) | < 0.001 |
LDL cholesterol, mmol/l | 3.15 (1.01) | − 0.32 (− 0.51 to − 0.13) | < 0.001 |
HDL cholesterol, mmol/l | 1.61 (0.45) | − 0.04 (− 0.08 to 0.01) | 0.069 |
Triglycerides, mmol/l | 1.37 (0.98) | − 0.01 (− 0.13 to 0.10) | 0.82 |
Fasting glucose, mmol/l | 5.87(0.85) | − 0.07 (− 0.23 to 0.10) | 0.40 |
Alcohol use, AUDIT-C score | 3.3 (2.6) | − 0.2 (− 0.5 to − 0.0) | 0.048 |
Physical activity, FIT index | 38 (19) | 2 (–1 to 5) | 0.10 |